Interventions
RECRUITMENT
Sitagliptin + Metformin [50 mg + 500 mg, 50 mg + 850 mg, 50 mg + 1000 mg] and Sitagliptin + Metformin Extended Release (XR) [50 mg + 500 mg, 50 mg + 1000 mg] were administered to patients who met the eligibility criteria, depending on the patient’s condition for 24 weeks. After recruitment, the patients were invited for three follow-ups, i.e., visit 1 at (4 to 6 weeks), visit 2 at (12 weeks), and visit 3 at (24 weeks) after initiation of therapy.